Tiziana Life Sciences Ltd (TLSA)
USD 0.99
(0.02%)
USD 0.99
(0.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.69 Million | -19.61 Million | -21.76 Million | -12.67 Million | -6.98 Million | -4.33 Million |
| Net Income | -17.24 Million | -15.39 Million | -26.65 Million | -30.07 Million | -10.28 Million | -9.45 Million |
| Depreciation & Amortization | 96 Thousand | 51 Thousand | 141 Thousand | 96.76 Thousand | 259.61 Thousand | 15.22 Thousand |
| Deferred income taxes | - | - | -512 Thousand | -2.27 Million | 1.29 Million | 2.37 Million |
| Stock-based compensation | 1.73 Million | -1.41 Million | 5.17 Million | 5.09 Million | 1.3 Million | 801.94 Thousand |
| Change in working capital | -1.58 Million | -1.16 Million | -773 Thousand | -312.08 Thousand | 295.01 Thousand | 1.84 Million |
| Other non-cash items | -625 Thousand | -1.69 Million | 866 Thousand | 14.77 Million | 158.65 Thousand | 83.74 Thousand |
| Investing Cash Flow | -1.25 Million | -3.99 Million | 130 Thousand | -134.91 Thousand | -3933.50 | -788.08 |
| Investments in PPE | - | - | -22 Thousand | -134.91 Thousand | -3933.50 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.25 Million | -3.99 Million | - | -120 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -3.99 Million | 152 Thousand | 120 Thousand | -4000.00 | - |
| Financing Cash Flow | 40 Thousand | -55 Thousand | -23 Thousand | 78.3 Million | 1.72 Million | 9.55 Million |
| Debt repayment | -119 Thousand | -55 Thousand | -152 Thousand | -294.37 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 24 Thousand | - | 129 Thousand | 78.06 Million | 1.93 Million | 10.87 Million |
| Other Financing Activities | 135 Thousand | -55 Thousand | -23 Thousand | 535.59 Thousand | -205.85 Thousand | -1.31 Million |
| Accounts receivables | -1.52 Million | -156 Thousand | 428 Thousand | -466.77 Thousand | -127.57 Thousand | - |
| Accounts payables | - | -1 Million | -685 Thousand | -1.03 Million | - | - |
| Inventory | - | 156 Thousand | -428 Thousand | 466.77 Thousand | - | - |
| Other working capital | -58 Thousand | -156 Thousand | -88 Thousand | 719.57 Thousand | 422.58 Thousand | - |
| Cash at beginning of period | 18.12 Million | 42.18 Million | 65.82 Million | 208.51 Thousand | 5.46 Million | 60.9 Thousand |
| Cash at end of period | 1.18 Million | 18.12 Million | 42.18 Million | 65.71 Million | 200.6 Thousand | 5.28 Million |
| Capital Expenditure | - | - | -22 Thousand | -134.91 Thousand | -3933.50 | - |
| Effect of forex changes on cash | -28 Thousand | -398 Thousand | -1.98 Million | 1.73 Million | 16 Thousand | -249 Thousand |
| Net cash flow / Change in cash | -16.93 Million | -24.06 Million | -23.63 Million | 65.5 Million | -5.26 Million | 5.22 Million |
| Free Cash Flow | -15.69 Million | -19.61 Million | -21.78 Million | -12.8 Million | -6.98 Million | -4.33 Million |
| Breakdown | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.24 Million | - | -15.39 Million | -10.88 Million | -4.51 Million | -26.65 Million |
| Depreciation & Amortization | 96 Thousand | - | 51 Thousand | 46 Thousand | 5000.00 | 141 Thousand |
| Deferred income taxes | - | - | - | - | - | -512 Thousand |
| Stock-based compensation | 1.73 Million | - | -1.41 Million | - | - | 5.17 Million |
| Change in working capital | -1.58 Million | - | -1.16 Million | 655.99 Thousand | -1.82 Million | -773 Thousand |
| Other non-cash items | -625 Thousand | - | -1.69 Million | 2.57 Million | -5.42 Million | 866 Thousand |
| Investing Cash Flow | -1.25 Million | - | -3.99 Million | -513 Thousand | -3.48 Million | 130 Thousand |
| Investments in PPE | - | - | - | - | - | -22 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -1.25 Million | - | -3.99 Million | -2.67 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -3.99 Million | 2.16 Million | -3.48 Million | 152 Thousand |
| Financing Cash Flow | 40 Thousand | - | -55 Thousand | -55 Thousand | - | -23 Thousand |
| Debt repayment | -119 Thousand | - | -55 Thousand | - | - | -152 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 24 Thousand | - | - | - | - | 129 Thousand |
| Other Financing Activities | - | - | -55 Thousand | - | - | -23 Thousand |
| Accounts receivables | - | - | -156 Thousand | -3000.00 | -153 Thousand | 428 Thousand |
| Accounts payables | - | - | -1 Million | - | - | -685 Thousand |
| Inventory | - | - | 156 Thousand | - | - | -428 Thousand |
| Other working capital | - | - | -156 Thousand | 658.99 Thousand | -1.66 Million | -88 Thousand |
| Cash at beginning of period | 18.12 Million | 18.12 Million | 42.18 Million | 26.54 Million | 53.33 Million | 65.82 Million |
| Cash at end of period | 1.18 Million | 18.12 Million | 18.12 Million | 18.12 Million | 26.54 Million | 42.18 Million |
| Capital Expenditure | - | - | - | - | - | -22 Thousand |
| Effect of forex changes on cash | -28 Thousand | - | -398 Thousand | -151 Thousand | - | -1.98 Million |
| Net cash flow / Change in cash | -16.93 Million | - | -24.06 Million | -8.42 Million | -26.78 Million | -23.63 Million |
| Free Cash Flow | -15.69 Million | - | -19.61 Million | -7.7 Million | -11.91 Million | -21.78 Million |
JST
600850
603266
SEII
CREDITACC
301392